Background: With the increasing adoption of robotic technology, robotic-assisted thoracic surgery (RATS) lobectomy has emerged as an alternative surgical approach to lobectomy performed with video-assisted thoracic surgery (VATS). However, in literature, a clear superiority of one technique over the other concerning clinical outcomes has not yet been clarified. Moreover, initial investment and maintenance costs of robotic technology can appear as prohibitive, and literature does not contain many studies proving that such costs can be or not offset by short-term clinical advantages. Aim of the study: This study intends to compare the short-term clinical outcomes and costs of RATS and VATS from the perspective of a thoracic surgery department at a national lung cancer referral center. It aims to assess whether the higher costs of robotic surgery are offset by improved clinical outcomes and related savings, making RATS cost-effective compared with VATS. Materials and methods: A retrospective study of VATS and RATS lobectomies performed within the Department of Thoracic Surgery of the University Hospital of Padova, Italy was conducted considering the period of time between 2023 and 2025, comparing patients’ baseline characteristics, surgical and clinical outcomes and economical costs associated with each approach by multivariable multiple linear regression analysis. Results: 402 patients in total were included in this study, 47 underwent RATS-lobectomy and 355 VATS-lobectomy. RATS was associated with significantly longer operative times (85.4 minutes) and higher operating-room costs than VATS. No significant differences were observed in conversion to thoracotomy, chest tube duration, length of stay, readmission, or complication rates, contrary to previous literature. Overall, RATS incurred significantly higher fixed and variable costs, amounting to a mean additional €2,708.13 per procedure. Conclusions: In this study we demonstrated that RATS involves longer operative times of 85.4 minutes and a mean additional cost of €2,708.13 per procedure compared with VATS, without significant improvements in short-term clinical outcomes.

Background: With the increasing adoption of robotic technology, robotic-assisted thoracic surgery (RATS) lobectomy has emerged as an alternative surgical approach to lobectomy performed with video-assisted thoracic surgery (VATS). However, in literature, a clear superiority of one technique over the other concerning clinical outcomes has not yet been clarified. Moreover, initial investment and maintenance costs of robotic technology can appear as prohibitive, and literature does not contain many studies proving that such costs can be or not offset by short-term clinical advantages. Aim of the study: This study intends to compare the short-term clinical outcomes and costs of RATS and VATS from the perspective of a thoracic surgery department at a national lung cancer referral center. It aims to assess whether the higher costs of robotic surgery are offset by improved clinical outcomes and related savings, making RATS cost-effective compared with VATS. Materials and methods: A retrospective study of VATS and RATS lobectomies performed within the Department of Thoracic Surgery of the University Hospital of Padova, Italy was conducted considering the period of time between 2023 and 2025, comparing patients’ baseline characteristics, surgical and clinical outcomes and economical costs associated with each approach by multivariable multiple linear regression analysis. Results: 402 patients in total were included in this study, 47 underwent RATS-lobectomy and 355 VATS-lobectomy. RATS was associated with significantly longer operative times (85.4 minutes) and higher operating-room costs than VATS. No significant differences were observed in conversion to thoracotomy, chest tube duration, length of stay, readmission, or complication rates, contrary to previous literature. Overall, RATS incurred significantly higher fixed and variable costs, amounting to a mean additional €2,708.13 per procedure. Conclusions: In this study we demonstrated that RATS involves longer operative times of 85.4 minutes and a mean additional cost of €2,708.13 per procedure compared with VATS, without significant improvements in short-term clinical outcomes.

VATS versus RATS for minimally invasive pulmonary lobectomy: a comprehensive analysis of clinical outcomes and costs

CIAMPALINI, GIUSEPPE ROBERTO
2025/2026

Abstract

Background: With the increasing adoption of robotic technology, robotic-assisted thoracic surgery (RATS) lobectomy has emerged as an alternative surgical approach to lobectomy performed with video-assisted thoracic surgery (VATS). However, in literature, a clear superiority of one technique over the other concerning clinical outcomes has not yet been clarified. Moreover, initial investment and maintenance costs of robotic technology can appear as prohibitive, and literature does not contain many studies proving that such costs can be or not offset by short-term clinical advantages. Aim of the study: This study intends to compare the short-term clinical outcomes and costs of RATS and VATS from the perspective of a thoracic surgery department at a national lung cancer referral center. It aims to assess whether the higher costs of robotic surgery are offset by improved clinical outcomes and related savings, making RATS cost-effective compared with VATS. Materials and methods: A retrospective study of VATS and RATS lobectomies performed within the Department of Thoracic Surgery of the University Hospital of Padova, Italy was conducted considering the period of time between 2023 and 2025, comparing patients’ baseline characteristics, surgical and clinical outcomes and economical costs associated with each approach by multivariable multiple linear regression analysis. Results: 402 patients in total were included in this study, 47 underwent RATS-lobectomy and 355 VATS-lobectomy. RATS was associated with significantly longer operative times (85.4 minutes) and higher operating-room costs than VATS. No significant differences were observed in conversion to thoracotomy, chest tube duration, length of stay, readmission, or complication rates, contrary to previous literature. Overall, RATS incurred significantly higher fixed and variable costs, amounting to a mean additional €2,708.13 per procedure. Conclusions: In this study we demonstrated that RATS involves longer operative times of 85.4 minutes and a mean additional cost of €2,708.13 per procedure compared with VATS, without significant improvements in short-term clinical outcomes.
2025
VATS versus RATS for minimally invasive pulmonary lobectomy: a comprehensive analysis of clinical outcomes and costs
Background: With the increasing adoption of robotic technology, robotic-assisted thoracic surgery (RATS) lobectomy has emerged as an alternative surgical approach to lobectomy performed with video-assisted thoracic surgery (VATS). However, in literature, a clear superiority of one technique over the other concerning clinical outcomes has not yet been clarified. Moreover, initial investment and maintenance costs of robotic technology can appear as prohibitive, and literature does not contain many studies proving that such costs can be or not offset by short-term clinical advantages. Aim of the study: This study intends to compare the short-term clinical outcomes and costs of RATS and VATS from the perspective of a thoracic surgery department at a national lung cancer referral center. It aims to assess whether the higher costs of robotic surgery are offset by improved clinical outcomes and related savings, making RATS cost-effective compared with VATS. Materials and methods: A retrospective study of VATS and RATS lobectomies performed within the Department of Thoracic Surgery of the University Hospital of Padova, Italy was conducted considering the period of time between 2023 and 2025, comparing patients’ baseline characteristics, surgical and clinical outcomes and economical costs associated with each approach by multivariable multiple linear regression analysis. Results: 402 patients in total were included in this study, 47 underwent RATS-lobectomy and 355 VATS-lobectomy. RATS was associated with significantly longer operative times (85.4 minutes) and higher operating-room costs than VATS. No significant differences were observed in conversion to thoracotomy, chest tube duration, length of stay, readmission, or complication rates, contrary to previous literature. Overall, RATS incurred significantly higher fixed and variable costs, amounting to a mean additional €2,708.13 per procedure. Conclusions: In this study we demonstrated that RATS involves longer operative times of 85.4 minutes and a mean additional cost of €2,708.13 per procedure compared with VATS, without significant improvements in short-term clinical outcomes.
VATS
RATS
Lobectomy
Costs
File in questo prodotto:
File Dimensione Formato  
Ciampalini_GiuseppeRoberto.pdf

Accesso riservato

Dimensione 1.36 MB
Formato Adobe PDF
1.36 MB Adobe PDF

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/119125